Загрузка...
Use of magnesium as a drug in chronic kidney disease
From chronic kidney disease (CKD) Stage 4 onwards, phosphate binders are needed in many patients to prevent the development of hyperphosphataemia, which can result in disturbed bone and mineral metabolism, cardiovascular disease and secondary hyperparathyroidism. In this review, we re-examine the us...
Сохранить в:
| Опубликовано в: : | Clin Kidney J |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455824/ https://ncbi.nlm.nih.gov/pubmed/26069822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfr168 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|